Figure 2From: Radiation dose ≥54 Gy and CA 19–9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation Overall survival for patients with CA 19–9 post-CRT minimum ≥ or < 90 U/mL. Back to article page